Phase II data for the MET inhibitor tepotinib in patients with advanced NSCLC and MET exon 14-skipping mutations Meeting Abstract
| Authors: | Felip, E.; Sakai, H.; Patel, J.; Horn, L.; Veillon, R.; Griesinger, F.; Bruns, R.; Scheele, J.; Paik, P. |
| Abstract Title: | Phase II data for the MET inhibitor tepotinib in patients with advanced NSCLC and MET exon 14-skipping mutations |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | non-small cell lung cancer; met inhibitor; tepotinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S347 |
| Language: | English |
| ACCESSION: | WOS:000454014500282 |
| DOI: | 10.1016/j.jtho.2018.08.299 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA12.01 -- Source: Wos |
